Adjuvanted H5N1 influenza vaccine offers good safety profile

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1608, 2007-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

M59-adjuvanted vaccine against H5N1 influenza antigenic in volunteers

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted; Prepandrix™): a guide to its use as an active immunization against influenza A subtype H5N1 virus

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 3, 2009-03 ,pp. : 5-9

Adis International

Access to resources Recommend Favorite

Adjuvant boosts H5N1 influenza vaccine immunogenicity

Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

HAd-H5HA vaccine protects against H5N1 influenza in mice

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

While the adjuvanted monovalent 2009 H1N1 pandemic influenza vaccine [Arepanrix] contains residual egg protein, it appears to be safe in children with egg allergy

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite